CI
ACCE-researchedOverview
ACCE thesis
Cigna runs two distinct businesses - Evernorth, a pharmacy benefit management and specialty drug services platform generating roughly 60% of total revenue, and Cigna Healthcare, a commercial and government health insurance operation - and the market is pricing them as if they're the same broken managed care story. Evernorth's Express Scripts gives Cigna formulary leverage and data scale that pure-play insurers can't replicate, and specialty pharmacy volumes tied to GLP-1 dispensing are running ahead of most estimates. The near-term catalyst is the company's ongoing evaluation of its Medicare Advantage exit, which should sharpen earnings quality and remove the segment that's been the primary drag on sentiment across the entire managed care group. At 8.5x forward earnings against a 16.3% ROE, the market is discounting Evernorth's durable cash generation as if the insurance losses are permanent - they're not. When MA headwinds lap in 2026 and Evernorth's specialty volumes are disaggregated from the noise, the multiple compression that's hit CI harder than peers looks like a misread worth owning.
- severeACCE score collapseScore dropped 27 points in 90 days (91→64), signaling rapid fundamental or sentiment deterioration requiring immediate investigation.
- highHeavy insider sellingLast 10 disclosed transactions show $59.11M in sales, zero buys - concentrated distribution at current prices.
- highQuarterly revenue decelerationQoQ revenue growth of -5.5% contrasts with +4.6% YoY, suggesting recent business momentum has sharply reversed.
- moderateRazor-thin net marginNet margin of only 2.3% leaves minimal buffer; any cost spike or reimbursement pressure could eliminate profitability quickly.
Walk me through this stock
Plain-English pros, cons, and what to watch. Pro feature.
Price
Valuation
INVESTORSix independent models converge on one confidence-weighted fair value, with full methodology and editable assumptions.
- +All six models: DCF, P/E and EV/EBITDA comps, Graham, dividend discount, residual income
- +Scenario bands, sensitivity tornado, and the 5-year historical valuation range
- +Editable DCF workbench with saved scenarios
Quality
INVESTORThe full quality picture: conviction breakdown, earnings quality, score history, and backtested returns.
- +Conviction score breakdown and earnings-quality grade
- +Growth / value / quality / momentum component scores
- +90-day score history and score-threshold backtests
Analysts
Wall Street consensus
The full analyst picture: the price-target distribution against the current price, forward consensus estimates, and how ACCE's own models compare.
- +Price-target low / average / high vs the current price, with implied upside
- +Forward revenue and EPS consensus by fiscal year
- +ACCE fair-value models lined up against the Street
Smart Money
PROFollow the institutions: 13F position changes, insider trades, and active 13D activist filings.
- +Quarter-over-quarter institutional position changes
- +Recent open-market insider transactions
- +Active 13D activist filings and top holders
Compare
Where it sits vs peers
Algorithmic peers (6)
| Ticker | Company | Mcap | P/E | ROE | D/E | Yield | Quality | |
|---|---|---|---|---|---|---|---|---|
| ELV | Elevance Health Inc. Common Stock | $89.1B | 18.2 | 11.1% | 0.73 | 1.7% | - | Compare |
| CVS | CVS Health Corporation Common Stock | $113.6B | 23.4 | 6.2% | 0.86 | 2.9% | - | Compare |
| HUM | Humana Inc. Common Stock | $46.4B | 36.5 | 6.9% | 0.70 | 0.9% | - | Compare |
| CNC | Centene Corporation Common Stock | $32.2B | - | -20.4% | 0.87 | 0.0% | - | Compare |
| UNH | UnitedHealth Group Incorporated Common Stock (DE) | $338.3B | 24.2 | 14.1% | 0.83 | 2.4% | - | Compare |
| MOH | Molina Healthcare Inc Common Stock | $10.5B | 1254.9 | -0.2% | 0.93 | 0.0% | - | Compare |
Sector report card
Where CI ranks against its sector peers on each metric.
News and Record
Press releases mentioning this company
- PR Newswire•Sep 16, 2026Is Volunteering Good for Your Health? New Research From The Cigna Group Finds a Strong Connection
- PR Newswire•Sep 9, 2026The Cigna Group to Host Investor Day on September 30
- PR Newswire•Aug 26, 2026Cigna Healthcare Connects Medical and Supplemental Benefits To Help People Better Manage Unexpected Health Costs
Ask anything, Pro feature
Ask questions about this stock in plain language. Answered from company fundamentals + recent valuations.